Cells mother who could heal dystrophy muscle.
-therapy with stem cells continue to be a solution to some problems that medicine cannot be resolved by conventional means
-recently, the journal Science Translational Medicine has published the study carried out by a team of Italian scientists who have tried the use of stem cells to treat muscular dystrophy in mice
Spain, 2011-September in healthy people the genes instruct the body to produce a muscle protein called dystrophin, but in people with certain types of muscular dystrophy these genes show mutations that make it impossible for the body to produce. Investigations carried out so far have failed to treat the disease with the inclusion of the normal gene for dystrophin in the muscles of the affected patients; but the team led by Giulio Cossu, the scientist San Rafaelle Institute of the University of Milan, solved it by creating a new method for the distribution of copies of the gene’s normal dystrophin in muscle.
It is still early, but the results suggest that stem cells offer promises of good transportation to the dystrophin gene and could be used in the treatment of this disease.
This study is one of the multitude of research areas that are currently using stem cells in experimental therapy, which demonstrates the potential for development in the coming years ”, says Alfonso Sánchez, Director Gerente of IVIDA.
About IVIDA
IVIDA is the Bank of lVI umbilical cord leading European in reproductive medicine with 22 clinics and presence in 8 countries. IVIDA offers a comprehensive service for preservation of umbilical cord, giving families retain the sample of the newborn in the public bank located at the headquarters in Madrid or in the private bank located at the headquarters of Lisbon. IVI, with more than 20 years in the service of the reproduction, IVIDA patients guarantees absolute control of the entire process, from the collection of the sample to the freezing of the same.
